相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Population Pharmacokinetics of Clozapine: A Systematic Review
Orwa Albitar et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Relationship between Clozapine-Induced Electroencephalogram Abnormalities and Serum Concentration of Clozapine in Japanese Patients with Treatment-Resistant Schizophrenia
Yuka Sugawara Kikuchi et al.
PSYCHIATRY INVESTIGATION (2019)
Clozapine Metabolism in East Asians and Caucasians A Pilot Exploration of the Prevalence of Poor Metabolizers and a Systematic Review
Can-Jun Ruan et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
C. Hiemke et al.
PHARMACOPSYCHIATRY (2018)
Clinical Pharmacokinetics of Atypical Antipsychotics: An Update
Massimo Carlo Mauri et al.
CLINICAL PHARMACOKINETICS (2018)
Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine
Domenico De Berardis et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2018)
The significance of sampling time in therapeutic drug monitoring of clozapine
M. I. Jakobsen et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Clozapine and Norclozapine Concentrations in Paired Human Plasma and Serum Samples
Handley SA et al.
THERAPEUTIC DRUG MONITORING (2017)
Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis
Britta Galling et al.
WORLD PSYCHIATRY (2017)
Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia
Jari Tiihonen et al.
JAMA PSYCHIATRY (2017)
International trends in clozapine use: a study in 17 countries
C. J. Bachmann et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Relationship between clozapine dose, serum concentration, and clinical outcome in children and adolescents in clinical practice
Christopher Wohkittel et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Reasons for discontinuing clozapine: A cohort study of patients commencing treatment
Sophie E. Legge et al.
SCHIZOPHRENIA RESEARCH (2016)
Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis
John Lally et al.
SCHIZOPHRENIA RESEARCH (2016)
Combination Analysis in Genetic Polymorphisms of Drug-Metabolizing Enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese Population
Tomoko Ota et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2015)
Prevalence of Therapeutic Drug Monitoring for Antidepressants and Antipsychotics in Stockholm, Sweden: A Longitudinal Analysis
Susanna M. Wallerstedt et al.
THERAPEUTIC DRUG MONITORING (2015)
Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum
Danielle S. Fisher et al.
FORENSIC SCIENCE INTERNATIONAL (2013)
Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?
Gary Remington et al.
PSYCHOPHARMACOLOGY (2013)
Therapeutic Drug Monitoring of Psychotropic Drugs in China: A Nationwide Survey
Wei Guo et al.
THERAPEUTIC DRUG MONITORING (2013)
A review of the use of clozapine levels to guide treatment and determine cause of death
Anne Stark et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2012)
Cytochrome P450 variations in different ethnic populations
Joseph McGraw et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia
Takefumi Suzuki et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Clozapine-related EEG changes and seizures: dose and plasma-level relationships
Seema Varma et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2011)
Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: Comparison with Korean, Chinese, and Caucasian populations
S. P. Myrand et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
The effect of smoking and cytochrome P450CYP1A2 genetic polymorphism on clozapine clearance and dose requirement
J van der Weide et al.
PHARMACOGENETICS (2003)
What is an adequate trial with clozapine? Therapeutic drug monitoring and time to response in treatment-refractory schizophrenia
PFJ Schulte
CLINICAL PHARMACOKINETICS (2003)
Is the time course of clozapine response correlated to the time course of clozapine plasma levels? A one-year prospective study in drug-resistant patients with schizophrenia
M Fabrazzo et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Clinical and biochemical correlates of 'high-dose' clozapine therapy for treatment - refractory schizophrenia
PF Buckley et al.
SCHIZOPHRENIA RESEARCH (2001)
Clozapine treatment of outpatients with schizophrenia: Outcome and long-term response patterns
A Breier et al.
PSYCHIATRIC SERVICES (2000)
Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics
E Spina et al.
PSYCHOPHARMACOLOGY (2000)
分享论文
